The Y Combinator-backed startup Breathe Well-Being has raised $5.5 million in its Series A round, led by Accel, according to ETtech report.
General Catalyst, 3one4 Capital and Scott Shleifer, the global managing director of New York-based investment firm Tiger Global also participated in the round.
“We will use the capital to deepen our tech expertise in product development and in building out our platform and team across functions,” Rohan Verma, co-founder and CEO, Breathe Well Being said.
The startup helps people prevent, manage and reverse Type 2 diabetes by using a personalised coach-driven approach. In May, the company said it had raised $1 million in a pre-Series A round, led by 3one4 Capital.
The company offers ‘No Outcome, No Pay’ where patients end up paying only if they see a significant reduction in the HbA1c levels, otherwise the fee is refunded.
In India, 150 million patients suffer from chronic lifestyle diseases such as Type 2 Diabetes, Polycystic Ovarian Disease, thyroid and hypertension.
Diabetes, if left untreated, can lead to potential complications that include heart disease, stroke, kidney damage, and nerve damage. Adults with diabetes have a two- to three-fold increased risk of heart attacks and strokes.
“We are really impressed at the customer stickiness around Breathe’s product and believe that the company has tremendous potential in scaling up this digital-led approach not just with diabetes but with any other conditions,” said Radhika Ananth, vice president, Accel.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.